Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for rebound pain after single-shot brachial plexus block
ChiCTR2100050289Phase 4Not yet recruiting
- Sponsor
- The Third Hospital of Hebei Medical University
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexamethasone and ropivacaine in postoperative pain (3 arms), sponsored by The Third Hospital of Hebei Medical University. Primary endpoints: Visual analog pain score, Systemic inflammation index and 5 more. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
dexamethasoneropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100050289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050289.